Optikira, LLC
Cleveland, United States · Founded 2015
- Headquarters
- Cleveland, Ohio
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
About
Optikira develops small-molecule drugs that modulate the unfolded protein response (UPR) pathway to prevent progressive cell death in diseases like retinitis pigmentosa and idiopathic pulmonary fibrosis. Founded in 2015 by BioMotiv in partnership with UCSF scientists, the company has received multiple NIH SBIR Phase I and Phase II grants and holds patents on IRE1 inhibitor compounds.
Summary
Optikira, LLC is a Biotech company based in Cleveland, United States, founded in 2015.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/optikira-llc"><img src="https://indexed.vc/api/badge/company/optikira-llc" alt="Optikira, LLC on Indexed.vc" width="260" height="76" /></a>